TALARIS THERAPEUTICS INC (TALS)
US87410C1045 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -74.77M | -73.89M | -47.83M | -22.71M | -18.16M | |||
| Depreciation Amortization | 1.20M | 1.38M | 623.00K | 450.00K | 380.00K | |||
| Change In Working Capital | 3.31M | 1.10M | 2.31M | 1.61M | -90.00K | |||
| Other non cash items | 11.38M | 10.56M | 4.91M | 1.43M | 200.00K | |||
| OPERATING CASH FLOW | -58.88M | -60.86M | -39.99M | -19.21M | -17.66M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -1.15M | -3.04M | -2.44M | -1.29M | -560.00K | |||
| Other Investing Activity | 52.80M | 58.71M | -93.95M | -132.01M | 0.00 | |||
| INVESTING CASH FLOW | 51.65M | 55.67M | -96.39M | -133.30M | -560.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 321.00K | 242.00K | 137.68M | 131.12M | 36.20M | |||
| Other Financing Activity | N/A | 0.00 | -277.00K | N/A | N/A | |||
| FINANCING CASH FLOW | 316.00K | 242.00K | 137.40M | 131.12M | 36.20M | |||
| CHANGE IN CASH | -6.92M | -4.94M | 1.03M | -21.39M | 17.98M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -58.88M | -60.86M | -39.99M | -19.21M | -17.66M | |||
| Capital Expenditure | -1.15M | -3.04M | -2.44M | -1.29M | -560.00K | |||
| FREE CASH FLOW | -60.03M | -63.90M | -42.42M | -20.50M | -18.22M | |||
All data in USD